Insights & Analysis

Practical perspectives on AI governance, intelligent automation, and regulatory strategy for life sciences.

Quality10 min read

The Hidden Cost of Deviation Investigations — And Why Life Sciences Companies Should Outsource Them

Deviation investigations consume more quality team bandwidth than almost any other activity. Most companies struggle with the same problems: inconsistent root cause analysis, overdue CAPAs, and repeat deviations. Here's why outsourcing to regulatory domain experts changes the math.

2026-03-05Read more →
AI Governance8 min read

AI Governance in Life Sciences: What Regulators Expect in 2026

From the EU AI Act to FDA draft guidance on AI/ML, regulated companies face a new reality. Here's the practical governance framework you need — not the theoretical one consultants sell.

2026-03-05Read →
Quality6 min read

Why Your QMS Is Already Obsolete (And What to Do About It)

Quality Management Systems were designed for a world of paper and periodic audits. AI-driven quality intelligence is the next evolution — and it's already here.

2026-03-04Read →
Cybersecurity7 min read

Pharma Cybersecurity: Beyond the Checkbox Audit

Life sciences companies treat cybersecurity like a compliance exercise. The threat actors targeting your clinical data and manufacturing systems don't care about your audit score.

2026-03-03Read →
Regulatory9 min read

SaMD + AI: What the FDA Actually Wants to See

Software as a Medical Device meets artificial intelligence. The intersection is where the biggest regulatory opportunities — and risks — live for diagnostics and digital health companies.

2026-03-01Read →

Stay Informed

Get the latest insights on AI governance, regulatory strategy, and intelligent automation delivered to your inbox.